PLIANT THERAPEUTICS, INC. Quarterly Depreciation in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Pliant Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q2 2019 to Q3 2024.
  • Pliant Therapeutics, Inc. Depreciation for the quarter ending September 30, 2024 was $500K, unchanged year-over-year.
  • Pliant Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2024 was $2.1M, a 15.5% increase year-over-year.
  • Pliant Therapeutics, Inc. annual Depreciation for 2023 was $1.84M, a 0.99% increase from 2022.
  • Pliant Therapeutics, Inc. annual Depreciation for 2022 was $1.82M, a 18.8% increase from 2021.
  • Pliant Therapeutics, Inc. annual Depreciation for 2021 was $1.54M, a 17.2% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.1M $500K $0 0% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $2.1M $600K +$200K +50% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $1.9M $513K +$61K +13.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $1.84M $489K +$21K +4.49% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $1.82M $500K $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $1.82M $400K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $1.82M $452K -$3K -0.66% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $1.82M $468K +$92K +24.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $1.73M $500K +$100K +25% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1.63M $400K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $1.63M $455K +$96K +26.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $1.54M $376K -$22K -5.53% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $1.56M $400K +$100K +33.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $1.46M $400K +$100K +33.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $1.36M $359K +$47K +15.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $1.31M $398K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 $300K $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $300K +$100K +50% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $312K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q3 2019 $300K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $200K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.